Waldmann, Thomas, 1930-
Anti-IL-2 receptor antibodies as models for cancer therapy [electronic resource] / Thomas A. Waldmann. - London : Henry Stewart Talks, 2007. - 1 online resource (1 streaming video file (45 min.) : color, sound). - Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Structure and function of IL-2 receptor -- Disorders of IL-2 receptor expression in disease -- IL-2R alpha-directed monoclonal antibody mediated therapy of leukemia and autoimmune diseases -- Anti-IL-2E alpha monoclonals armed with toxins or radionuclides -- IL-15 and its use of the IL-/IL-15 beta receptor -- IL-2/IL-15 R beta receptor directed therapy for leukemia and autoimmune diseases -- The IL-2R alpha as a target in the elimination of CD4+ CD25+ T-regs (suppressor cells).
Access restricted to subscribers.
Mode of access: World Wide Web.
1394 Henry Stewart Talks
Antibodies, Monoclonal--therapeutic use.
Autoimmune Diseases--therapy.
Leukemia--therapy.
Receptors, Interleukin-2.
Anti-IL-2 receptor antibodies as models for cancer therapy [electronic resource] / Thomas A. Waldmann. - London : Henry Stewart Talks, 2007. - 1 online resource (1 streaming video file (45 min.) : color, sound). - Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Structure and function of IL-2 receptor -- Disorders of IL-2 receptor expression in disease -- IL-2R alpha-directed monoclonal antibody mediated therapy of leukemia and autoimmune diseases -- Anti-IL-2E alpha monoclonals armed with toxins or radionuclides -- IL-15 and its use of the IL-/IL-15 beta receptor -- IL-2/IL-15 R beta receptor directed therapy for leukemia and autoimmune diseases -- The IL-2R alpha as a target in the elimination of CD4+ CD25+ T-regs (suppressor cells).
Access restricted to subscribers.
Mode of access: World Wide Web.
1394 Henry Stewart Talks
Antibodies, Monoclonal--therapeutic use.
Autoimmune Diseases--therapy.
Leukemia--therapy.
Receptors, Interleukin-2.